$ZLAB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zai Lab Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Zai Lab Ltd. Get notifications about new insider transactions in Zai Lab Ltd for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Option Exercise | M | 18.00 | 8,000 | 144,000 | 52,000 | |
Jun 17 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Option Exercise | M | 20.90 | 8,000 | 167,200 | 60,000 | |
Jun 17 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Sell | S | 161.64 | 8,000 | 1,293,120 | 0 | 8 K to 0 (-100.00 %) |
Jun 17 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Buy | M | 18.00 | 8,000 | 144,000 | 8,000 | 0 to 8 K |
Jun 17 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Sell | S | 162.71 | 8,000 | 1,301,680 | 0 | 8 K to 0 (-100.00 %) |
Jun 17 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Buy | M | 20.90 | 8,000 | 167,200 | 8,000 | 0 to 8 K |
May 06 2021 | ZLAB | Zai Lab Ltd | DIEKMAN JOHN D | Director | Sell | S | 153.62 | 1,000 | 153,620 | 62,852 | 63.9 K to 62.9 K (-1.57 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 169.78 | 54 | 9,168 | 786,430 | 786.5 K to 786.4 K (-0.01 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 168.95 | 347 | 58,626 | 786,484 | 786.8 K to 786.5 K (-0.04 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 167.86 | 240 | 40,286 | 786,831 | 787.1 K to 786.8 K (-0.03 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 166.61 | 770 | 128,290 | 787,071 | 787.8 K to 787.1 K (-0.10 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 165.40 | 779 | 128,847 | 787,841 | 788.6 K to 787.8 K (-0.10 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 164.37 | 1,488 | 244,583 | 788,620 | 790.1 K to 788.6 K (-0.19 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 163.43 | 1,077 | 176,014 | 790,108 | 791.2 K to 790.1 K (-0.14 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 162.58 | 2,349 | 381,900 | 791,185 | 793.5 K to 791.2 K (-0.30 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 161.43 | 1,325 | 213,895 | 793,534 | 794.9 K to 793.5 K (-0.17 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 160.52 | 2,886 | 463,261 | 794,859 | 797.7 K to 794.9 K (-0.36 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 159.37 | 1,691 | 269,495 | 797,745 | 799.4 K to 797.7 K (-0.21 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 158.26 | 8,812 | 1,394,587 | 799,436 | 808.2 K to 799.4 K (-1.09 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 157.27 | 3,284 | 516,475 | 808,248 | 811.5 K to 808.2 K (-0.40 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 156.24 | 10,466 | 1,635,208 | 811,532 | 822 K to 811.5 K (-1.27 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 155.34 | 13,379 | 2,078,294 | 821,998 | 835.4 K to 822 K (-1.60 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 168.21 | 1,013 | 170,397 | 835,377 | 836.4 K to 835.4 K (-0.12 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 166.71 | 433 | 72,185 | 836,390 | 836.8 K to 836.4 K (-0.05 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 165.50 | 3,117 | 515,864 | 836,823 | 839.9 K to 836.8 K (-0.37 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 164.60 | 5,114 | 841,764 | 839,940 | 845.1 K to 839.9 K (-0.61 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 163.58 | 2,720 | 444,938 | 845,054 | 847.8 K to 845.1 K (-0.32 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 162.54 | 7,171 | 1,165,574 | 847,774 | 854.9 K to 847.8 K (-0.84 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 161.60 | 14,867 | 2,402,507 | 854,945 | 869.8 K to 854.9 K (-1.71 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 160.64 | 12,634 | 2,029,526 | 869,812 | 882.4 K to 869.8 K (-1.43 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 159.59 | 6,885 | 1,098,777 | 882,446 | 889.3 K to 882.4 K (-0.77 %) |
May 04 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 158.65 | 8,210 | 1,302,517 | 889,331 | 897.5 K to 889.3 K (-0.91 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Option Exercise | M | 18.92 | 10,000 | 189,200 | 470,000 | |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Sell | S | 164.15 | 200 | 32,830 | 207,000 | 207.2 K to 207 K (-0.10 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Sell | S | 163.38 | 4,000 | 653,520 | 207,200 | 211.2 K to 207.2 K (-1.89 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Sell | S | 162.55 | 5,800 | 942,790 | 211,200 | 217 K to 211.2 K (-2.67 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Buy | M | 18.92 | 10,000 | 189,200 | 217,000 | 207 K to 217 K (+4.83 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Option Exercise | M | 20.90 | 8,000 | 167,200 | 84,000 | |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Option Exercise | M | 20.90 | 8,000 | 167,200 | 92,000 | |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Sell | S | 161.99 | 8,000 | 1,295,920 | 0 | 8 K to 0 (-100.00 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Buy | M | 20.90 | 8,000 | 167,200 | 8,000 | 0 to 8 K |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Sell | S | 150.20 | 8,000 | 1,201,600 | 0 | 8 K to 0 (-100.00 %) |
Apr 21 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Buy | M | 20.90 | 8,000 | 167,200 | 8,000 | 0 to 8 K |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 135.94 | 940 | 127,784 | 897,541 | 898.5 K to 897.5 K (-0.10 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 135.17 | 8,017 | 1,083,658 | 898,481 | 906.5 K to 898.5 K (-0.88 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 134.40 | 10,369 | 1,393,594 | 906,498 | 916.9 K to 906.5 K (-1.13 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 133.12 | 313 | 41,667 | 916,867 | 917.2 K to 916.9 K (-0.03 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 131.83 | 1,720 | 226,748 | 917,180 | 918.9 K to 917.2 K (-0.19 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 130.34 | 577 | 75,206 | 918,900 | 919.5 K to 918.9 K (-0.06 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 129.21 | 1,484 | 191,748 | 919,477 | 921 K to 919.5 K (-0.16 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 128.38 | 9,689 | 1,243,874 | 920,961 | 930.7 K to 921 K (-1.04 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 127.55 | 19,444 | 2,480,082 | 930,650 | 950.1 K to 930.7 K (-2.05 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 126.62 | 2,023 | 256,152 | 950,094 | 952.1 K to 950.1 K (-0.21 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 125.25 | 860 | 107,715 | 952,117 | 953 K to 952.1 K (-0.09 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 124.39 | 3,614 | 449,545 | 952,977 | 956.6 K to 953 K (-0.38 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 123.20 | 1,278 | 157,450 | 956,591 | 957.9 K to 956.6 K (-0.13 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 132.42 | 589 | 77,995 | 957,869 | 958.5 K to 957.9 K (-0.06 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 131.09 | 492 | 64,496 | 958,458 | 959 K to 958.5 K (-0.05 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 129.63 | 1,817 | 235,538 | 958,950 | 960.8 K to 959 K (-0.19 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 128.65 | 2,700 | 347,355 | 960,767 | 963.5 K to 960.8 K (-0.28 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 127.69 | 4,510 | 575,882 | 963,467 | 968 K to 963.5 K (-0.47 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 126.45 | 8,690 | 1,098,851 | 967,977 | 976.7 K to 968 K (-0.89 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 125.70 | 20,494 | 2,576,096 | 976,667 | 997.2 K to 976.7 K (-2.06 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Sell | S | 124.63 | 11,492 | 1,432,248 | 997,161 | 1 M to 997.2 K (-1.14 %) |
Apr 07 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Gift | G | 0.00 | 16,000 | 0 | 1,008,653 | 1 M to 1 M (-1.56 %) |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,050 | 0 | 5,050 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Reinhart Harald | Chief Medical Offic ... | Option Exercise | A | 130.96 | 26,650 | 3,490,084 | 26,650 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Liang Yi | CCO & President, Gr ... | Option Exercise | A | 0.00 | 3,650 | 0 | 3,650 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Liang Yi | CCO & President, Gr ... | Option Exercise | A | 130.96 | 20,000 | 2,619,200 | 20,000 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | Chief Legal Officer | Option Exercise | A | 0.00 | 4,150 | 0 | 4,150 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | Chief Legal Officer | Option Exercise | A | 130.96 | 22,000 | 2,881,120 | 22,000 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Option Exercise | A | 0.00 | 17,000 | 0 | 17,000 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Du Ying | Chairwoman & CEO | Option Exercise | A | 130.96 | 87,000 | 11,393,520 | 87,000 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Sandler Alan B. | Head of Global Dev. ... | Option Exercise | A | 0.00 | 5,300 | 0 | 5,300 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Sandler Alan B. | Head of Global Dev. ... | Option Exercise | A | 130.96 | 28,000 | 3,666,880 | 28,000 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Cho William Ki Chul | Chief Financial Off ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Apr 05 2021 | ZLAB | Zai Lab Ltd | Cho William Ki Chul | Chief Financial Off ... | Option Exercise | A | 130.96 | 24,050 | 3,149,588 | 24,050 | |
Mar 30 2021 | ZLAB | Zai Lab Ltd | Chen Kai-Xian | Director | Sell | S | 142.53 | 4,302 | 613,164 | 24,662 | 29 K to 24.7 K (-14.85 %) |
Mar 30 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Option Exercise | M | 18.92 | 20,000 | 378,400 | 480,000 | |
Mar 30 2021 | ZLAB | Zai Lab Ltd | Fu Tao | President & COO | Buy | M | 18.92 | 20,000 | 378,400 | 207,000 | 187 K to 207 K (+10.70 %) |
Jan 20 2021 | ZLAB | Zai Lab Ltd | MOULDER LEON O JR | Director | Grant | A | 0.00 | 3,852 | 0 | 13,852 | 10 K to 13.9 K (+38.52 %) |
Jan 20 2021 | ZLAB | Zai Lab Ltd | Lis William | Director | Grant | A | 0.00 | 3,852 | 0 | 28,277 | 24.4 K to 28.3 K (+15.77 %) |
Jan 20 2021 | ZLAB | Zai Lab Ltd | WIRTH PETER | Director | Grant | A | 0.00 | 3,852 | 0 | 338,852 | 335 K to 338.9 K (+1.15 %) |
Jan 20 2021 | ZLAB | Zai Lab Ltd | DIEKMAN JOHN D | Director | Grant | A | 0.00 | 3,852 | 0 | 63,852 | 60 K to 63.9 K (+6.42 %) |
Jan 20 2021 | ZLAB | Zai Lab Ltd | Chen Kai-Xian | Director | Grant | A | 0.00 | 3,852 | 0 | 28,964 | 25.1 K to 29 K (+15.34 %) |
Page: 1